Citation 142666

HWANG,BY: KIM,SE: KIM,YH: KIM,HS: HONG,YS: RO,JS: LEE,KS: LEE,JJ:. (1999). PREGNANE GLYCOSIDE MULTIDRUG-RESISTANCE MODULATORS FROM CYNANCHUM WILFORDII.. 62(4)

Citation Details

Title	PREGNANE GLYCOSIDE MULTIDRUG-RESISTANCE MODULATORS FROM CYNANCHUM WILFORDII.
Authors	HWANG,BY: KIM,SE: KIM,YH: KIM,HS: HONG,YS: RO,JS: LEE,KS: LEE,JJ:
Year	1999
Volume	62
Issue	4

Summary

Year: 1999

Journal: Unknown

Organisms and Their Experiments (1)

Cynanchum wilfordii (ASCLEPIADACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATA	GAGAMININ-3-O-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE	None
2	MULTIDRUG RESISTANCE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GAGAMININ-3-O-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE	WEAK ACTIVITY
3	MULTIDRUG RESISTANCE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GAGAMININ-3-O-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE	WEAK ACTIVITY
4	MULTIDRUG RESISTANCE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GAGAMININ-3-O-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE	STRONG ACTIVITY
5	MULTIDRUG RESISTANCE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GAGAMININ-3-O-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE	ACTIVE
6	MULTIDRUG RESISTANCE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GAGAMININ-3-O-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE	ACTIVE
7	MULTIDRUG RESISTANCE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GAGAMININ-3-O-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE	ACTIVE
8	MULTIDRUG RESISTANCE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GAGAMININ-3-O-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE	WEAK ACTIVITY
9	MULTIDRUG RESISTANCE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GAGAMININ-3-O-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE	ACTIVE
10	MULTIDRUG RESISTANCE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GAGAMININ-3-O-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE	ACTIVE
11	MULTIDRUG RESISTANCE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GAGAMININ-3-O-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE	ACTIVE
12	MULTIDRUG RESISTANCE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GAGAMININ-3-O-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE	ACTIVE
13	MULTIDRUG RESISTANCE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GAGAMININ-3-O-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE	ACTIVE
14	MULTIDRUG RESISTANCE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GAGAMININ-3-O-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE	WEAK ACTIVITY
15	MULTIDRUG RESISTANCE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GAGAMININ-3-O-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE	ACTIVE
16	MULTIDRUG RESISTANCE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GAGAMININ-3-O-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE	ACTIVE
17	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATA	WILFOSIDE K-1-N	None
18	MULTIDRUG RESISTANCE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFOSIDE K-1-N	WEAK ACTIVITY
19	MULTIDRUG RESISTANCE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFOSIDE K-1-N	WEAK ACTIVITY
20	MULTIDRUG RESISTANCE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFOSIDE K-1-N	STRONG ACTIVITY
21	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATA	WILFOSIDE C-1-N	None
22	MULTIDRUG RESISTANCE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFOSIDE C-1-N	EQUIVOCAL
23	MULTIDRUG RESISTANCE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFOSIDE C-1-N	EQUIVOCAL
24	MULTIDRUG RESISTANCE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WILFOSIDE C-1-N	ACTIVE
25	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATA	CYNAURICUOSIDE A	None
26	MULTIDRUG RESISTANCE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CYNAURICUOSIDE A	INACTIVE
27	MULTIDRUG RESISTANCE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CYNAURICUOSIDE A	INACTIVE
28	MULTIDRUG RESISTANCE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CYNAURICUOSIDE A	INACTIVE

Citation 142666

Citation Details

Summary

Organisms and Their Experiments (1)

Cynanchum wilfordii (ASCLEPIADACEAE)

Show SPARQL Queries (1)

Query 1